LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP 4
Accession 0001213900-20-027008
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:44 PM ET
Size
26.6 KB
Accession
0001213900-20-027008
Insider Transaction Report
- Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total - Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total
- Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total
- Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total
- Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total - Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total
- Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total - Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total
- Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total
- Sale
Common Stock
2020-08-19$2.26/sh−74,020$167,026→ 761,680 total - Sale
Common Stock
2020-08-19$2.25/sh−13,251$29,760→ 136,237 total - Sale
Common Stock
2020-08-21$1.66/sh−18,432$30,540→ 117,805 total - Sale
Common Stock
2020-08-25$1.13/sh−84,816$96,147→ 573,902 total - Sale
Common Stock
2020-08-25$1.13/sh−15,184$17,106→ 102,621 total - Sale
Common Stock
2020-08-21$1.66/sh−102,962$171,071→ 658,718 total - Sale
Common Stock
2020-08-26$1.25/sh−85,106$106,195→ 17,515 total - Sale
Common Stock
2020-08-26$1.24/sh−475,512$591,299→ 98,390 total
Footnotes (2)
- [F1]These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
- [F2]These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
Documents
Issuer
Teligent, Inc.
CIK 0000352998
Related Parties
1- filerCIK 0001269417
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:44 PM ET
- Size
- 26.6 KB